Neil Kumar

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and call appearances connecting this person to public companies.

BBIO

Current role

CEO, Board Member

8 appearances Latest appearance 2026-08-10

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$1,044,000	$1,404,000	$10,606,275	$1,874,992	—	$15,318	$14,944,585
2024	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$987,539	$1,038,800	$12,541,433	$999,991	—	$14,160	$15,581,923
2023	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$742,000	$779,100	$6,123,793	$4,499,993	—	$13,740	$12,158,626
2022	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$1,106,000	$940,100	$4,571,519	—	—	$56,818	$6,674,437
2021	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$725,000	—	$2,638,134	$22,230,967	—	$32,858	$25,626,959
2020	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$550,000	$825,000	$2,368,511	$6,299,998	—	$11,400	$10,054,909
2019	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$502,765	$360,000	$13,863,445	$11,573,049	—	$34,804	$26,334,063
2018	BridgeBio Pharma, Inc. (BBIO)	Chief Executive Officer	$450,000	—	—	—	—	—	$450,000

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.